Quantifiable Nanoparticle Characterization using TEM

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$193,829.00
Award Year:
2010
Program:
SBIR
Phase:
Phase I
Contract:
1R43RR028166-01
Award Id:
96500
Agency Tracking Number:
RR028166
Solicitation Year:
n/a
Solicitation Topic Code:
NCRR
Solicitation Number:
n/a
Small Business Information
NANOIMAGING SERVICES, INC., 10931 N TORREY PINES RD, STE 108, LA JOLLA, CA, 92037
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
826400629
Principal Investigator:
JOEL QUISPE
() -
Business Contact:
CLINTON POTTER
() -
cpotter@nanoimagingservices.com
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): Characterization of nanoparticles and biologics is a critical step in the development of important new pharmaceutical therapeutics as, in many cases, preclinical characterization is the rate-limiting phase of the commer cialization process. Nanoparticle therapeutics poses unique challenges for characterization that require an interdisciplinary approach in which several orthogonal methods are required to provide a complete picture. Cryo-electron microscopy, with its unique capability for providing exact visual information of size, shape, morphology, and aggregation of a sample in its natural hydrated state, is a powerful additional tool in the armamentarium of characterization techniques applied to nanoparticles. NanoImagin g Services, Inc. was established in 2007 in order to provide cryoEM imaging services specifically focused on the characterization of biologics and nanoparticles. Over the past 18 months it has become clear that there is a critical need for more quantitativ e analysis of multiple cryoEM images. The images must be processed, analyzed and evaluated with the goal of providing numerical data that can be used for assessing the characteristics of the samples and comparing these characteristics to the results obtain ed from other orthogonal methods. Quantitation is critical for assessing lot-to-lot comparisons, quality assurance and control, monitoring samples over time, and when providing data to the regulatory agencies. Here we request support to undertake a 6 month study to determine the feasibility of developing several quantitative characterization protocols that are designed to address specific needs in the research and development of new biologics and nanoparticles as therapeutics. Specifically we will develop q uantitative tools to characterize particle morphology and aggregation state and test and validate the methods using a number of samples of high interest as pharmaceutical therapeutics. PUBLIC HEALTH RELEVANCE: Arguably two of the fastest growing sec tors of the biopharmaceutical industry are the production of biologics as therapeutic agents and nanoparticles as drug delivery vehicles. There is considerable evidence that the physical properties of biologics and nanoparticles is tightly linked to their functional behavior and may thus be a determining factor in the biodistribution, safety, and efficacy of the pharmaceutical product. Cryo- electron microscopy, with its unique potential for providing quantitative information of size, shape, morphology, and aggregation of a sample in its natural hydrated state, is a powerful additional tool in the armamentarium of characterization techniques applied to nanoparticles.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government